National Research (NRCIB) vs. Its Peers Head-To-Head Comparison

National Research (NASDAQ: NRCIB) is one of 32 public companies in the “Commercial physical research” industry, but how does it compare to its peers? We will compare National Research to related companies based on the strength of its dividends, valuation, risk, institutional ownership, earnings, analyst recommendations and profitability.


National Research pays an annual dividend of $2.40 per share and has a dividend yield of 5.0%. National Research pays out 413.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. As a group, “Commercial physical research” companies pay a dividend yield of 3.5% and pay out 241.4% of their earnings in the form of a dividend.

Earnings and Valuation

This table compares National Research and its peers revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
National Research $117.56 million $22.94 million 82.83
National Research Competitors $806.34 million $48.27 million 16.28

National Research’s peers have higher revenue and earnings than National Research. National Research is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Institutional and Insider Ownership

2.5% of National Research shares are owned by institutional investors. Comparatively, 45.7% of shares of all “Commercial physical research” companies are owned by institutional investors. 39.1% of National Research shares are owned by company insiders. Comparatively, 17.2% of shares of all “Commercial physical research” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Volatility and Risk

National Research has a beta of 0.38, indicating that its stock price is 62% less volatile than the S&P 500. Comparatively, National Research’s peers have a beta of 3.13, indicating that their average stock price is 213% more volatile than the S&P 500.


This table compares National Research and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
National Research 19.52% 27.45% 19.09%
National Research Competitors -258.33% -66.39% -24.53%

Analyst Ratings

This is a summary of recent ratings for National Research and its peers, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Research 0 0 0 0 N/A
National Research Competitors 86 490 1171 37 2.65

As a group, “Commercial physical research” companies have a potential upside of 29.47%. Given National Research’s peers higher probable upside, analysts clearly believe National Research has less favorable growth aspects than its peers.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provide actionable information and analysis to healthcare organizations and payers across a range of mission-critical, constituent-related elements, including patient experience, satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement. The company offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. It also provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. The company offers transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, increase patient satisfaction and support safe care transitions; and risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs. It provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems and post-acute providers, such as home health, long term care, hospice, and payer organizations. The company was founded in 1981 and is headquartered in Lincoln, Nebraska.

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with's FREE daily email newsletter.

Leave a Reply